Variable | Training Cohort (n = 210) | Test Cohort (n = 90) | ||||
---|---|---|---|---|---|---|
Endoscopic Remission (n = 54) | Endoscopic Activity (n = 156) | P value | Endoscopic Remission (n = 21) | Endoscopic Activity (n = 69) | P value | |
CDAI | 77 (49-100.25) | 130 (92-166.75) | < 0.05 | 70 (40.5–94.5) | 149 (99–203) | < 0.05 |
HB (g/L) | 140 (122-150.25) | 121.5 (108.3-138.8) | < 0.05 | 141 (112.5–141) | 123 (105–135) | < 0.05 |
WBC(×109/L) | 5.41 (4.28–6.46) | 5.5 (4.27–7.28) | 0.484 | 5.99 (4.56–6.67) | 6.24 (5.2–8.43) | 0.144 |
N (×109/L) | 3.17 (2.45–4.02) | 3.57 (2.69–5.04) | < 0.05 | 3.05 (2.69–3.53) | 4.18 (3.23–5.92) | < 0.05 |
L (×109/L) | 1.52 (1.1–2.3) | 1.2 (0.86–1.57) | < 0.05 | 2.04 (1.34–2.6) | 1.39 (0.99–1.92) | < 0.05 |
PLT (×109/L) | 205 (170.75–233.5) | 247.5 (200-315.5) | < 0.05 | 211 (176.5-231.5) | 273 (231–331) | < 0.05 |
CRP (mg/L) | 0.77 (0.5–3.48) | 13.9 (4.65–37.62) | < 0.05 | 1.21 (0.38–4.53) | 9.47 (3.22–34.3) | < 0.05 |
ALB (g/L) | 41.35 (38.38–44.1) | 37.35 (33.2–41.8) | < 0.05 | 45.9 (42.8–47.7) | 41.5 (36.2–44.8) | < 0.05 |
NLR | 2.1 (1.38–3.27) | 3.01 (2.06–4.78) | < 0.05 | 1.76 (1.11–2.41) | 2.94 (2.12–4.79) | < 0.05 |
PLpR | 6.27 (5.11–9.3) | 11.5 (7-19.33) | < 0.05 | 5.57 (4.88–7.84) | 12.96 (9.9-17.89) | < 0.05 |
PLT/ALB | 4.88 (4.06–5.89) | 6.38 (4.96–8.86) | < 0.05 | 4.6 (3.7–5.63) | 7.48 (5.72–8.84) | < 0.05 |
CRP/ALB | 0.02 (0.01–0.09) | 0.36 (0.12–1.11) | < 0.05 | 0.03 (0.01–0.11) | 0.26 (0.07–0.89) | < 0.05 |